Therapy of Hepatitis C - Back to the Future

被引：92
|
作者：
Liang, T. Jake [1 ]
Ghany, Marc G. [1 ]
机构：
[1] NIDDK, NIH, Bethesda, MD 20892 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 370卷 / 21期
关键词：
VIRUS-INFECTION; CHRONIC HCV; SOFOSBUVIR; ABT-450/R-OMBITASVIR; DASABUVIR; LEDIPASVIR; RIBAVIRIN;
D O I：
10.1056/NEJMe1403619
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2043 / 2047
页数：5
相关论文
共 50 条
  • [31] Diagnosis and management of hepatitis C
    Vine, Louisa J.
    Sieberhagen, Cyril
    Cramp, Matthew E.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2015, 76 (11) : 625 - 630
  • [32] Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents
    Quintero, Jesus
    Juamperez, Javier
    Julio, Ecaterina
    Cabello, Vanessa
    Mercadal-Hally, Maria
    Soler-Palacin, Pere
    Segarra, Oscar
    Rodrigo, Carlos
    ANALES DE PEDIATRIA, 2019, 90 (03): : 141 - 147
  • [33] Hepatitis C following liver transplantation: current approach and future research opportunities
    Cosar, Arif M.
    Durand, Christine M.
    Cameron, Andrew M.
    Gurakar, Ahmet
    CURRENT OPINION IN INFECTIOUS DISEASES, 2016, 29 (04) : 346 - 352
  • [34] Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C
    Davitkov, Perica
    Chandar, Apoorva Krishna
    Hirsch, Amy
    Compan, Anita
    Silveira, Marina G.
    Anthony, Donald D.
    Smith, Suzanne
    Gideon, Clare
    Bonomo, Robert A.
    Falck-Ytter, Yngve
    PLOS ONE, 2016, 11 (10):
  • [35] Efficacy of Combination Therapy Sofosbuvir, Daclatasvir and Ribavirin in Patients of Hepatitis C
    Quddus, Muhammad Abdul
    Zaib, Jahangir
    Munawar, Rukhsana
    Siddiq, Shazia
    Tahir, Rabia
    Kiani, Rizwan Saeed
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (09): : 2823 - 2825
  • [36] Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients
    Ueda, Yoshihide
    Uemoto, Shinji
    TRANSPLANTATION, 2016, 100 (01) : 54 - 60
  • [37] Optimal therapy in genotype 4 chronic hepatitis C: finally cured?
    Abdel-Razek, Wael
    Waked, Imam
    LIVER INTERNATIONAL, 2015, 35 : 27 - 34
  • [38] Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response
    Cloherty, Gavin
    Chevaliez, Stephane
    Sarrazin, Christoph
    Herman, Christine
    Holzmayer, Vera
    Dawson, George
    Maasoumy, Benjamin
    Vermehren, Johannes
    Wedemeyer, Heiner
    Feld, Jordan J.
    Pawlotsky, Jean-Michel
    SCIENTIFIC REPORTS, 2016, 6
  • [39] Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting
    Siederdissen, Christoph Hoener Zu
    Maasoumy, Benjamin
    Deterding, Katja
    Port, Kerstin
    Sollik, Lisa
    Mix, Carola
    Kirschner, Janina
    Cornberg, Janet
    Manns, Michael P.
    Wedemeyer, Heiner
    Cornberg, Markus
    LIVER INTERNATIONAL, 2015, 35 (07) : 1845 - 1852
  • [40] Sofosbuvir (Sovaldi) for the treatment of hepatitis C
    Lam, Brian
    Henry, Linda
    Younossi, Zobair
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (05) : 555 - 566
12345